Related Experiment Video
Updated: Jul 4, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Vascular calcification and atherosclerosis in hemodialysis patients: what can we learn from the routine clinical
Saso Gelev1, Goce Spasovski, Sonja Dzikova
1Department of Nephrology, University Clinical Center, Vodnjanska 17, 1000 Skopje, Republic of Macedonia.
Insights
Hemodialysis patients frequently develop arterial calcifications, increasing their risk of cardiovascular and other complications. Early screening for arterial calcification in chronic kidney disease patients is recommended.
Area of Science:
- Nephrology
- Cardiovascular Medicine
- Radiology
Background:
- Hemodialysis (HD) patients exhibit a heightened risk for arterial intimal calcification (AIC) and medial calcification (AMC).
- Arterial calcification is a significant comorbidity in patients undergoing hemodialysis.
Purpose of the Study:
- To evaluate the prevalence of arterial intimal calcification (AIC) and medial calcification (AMC) in hemodialysis (HD) patients.
- To assess the association between arterial calcifications and atherosclerotic lesions in the common carotid arteries (CCA).
Main Methods:
- A cross-sectional study involving 153 HD patients.
- Plain radiography of the pelvis was used to assess AIC and AMC.
- High-resolution B-mode ultrasonography of the CCA was employed to detect atherosclerotic plaques.
Main Results:
- A high prevalence of AIC (35.3%) and AMC (35.9%) was observed in HD patients.
- Patients with AIC showed a significantly higher prevalence of CCA atherosclerotic plaques (78.6%) and a greater burden of atherosclerotic complications.
- No significant differences in HD-specific risk factors or bone metabolism markers were found between calcified and non-calcified groups, though the non-calcified group had a higher proportion meeting K/DOQI guidelines.
Conclusions:
- Arterial calcifications (AIC and AMC) are common in the hemodialysis population.
- Screening for arterial calcifications is advised for chronic kidney disease patients, including those in pre-dialysis stages.
- Adherence to K/DOQI guidelines for bone and mineral metabolism is crucial for preventing arterial calcifications in HD patients.
Background:
Hemodialysis (HD) patients are at increased risk for arterial intimal (AIC) and medial calcification (AMC).
Methods:
In a cross-sectional study on 153 HD patients we evaluated the presence of AIC and AMC using plain radiography of the pelvis and the presence of atherosclerotic lesions using high-resolution B-mode ultrasonography of the common carotid arteries (CCA).
Results:
The radiography of the pelvis confirmed the frequent presence of AIC (35.3%) and AMC (35.9%) in our HD patients. Arterial calcification was absent (non calcified-NC) in a minority of patients (28.8%). Patients with AIC had significantly higher prevalence of atherosclerotic plaques on CCA (78.6%) compared with both other groups and a higher number of documented atherosclerotic complications, such as cardiovascular (85.2%), cerebrovascular (33.3%) and peripheral arterial disease (38.9%) in comparison with the NC patients. According to the 1-year calculated data from patient records, there were no significant differences in the specific HD risks, such as the dose of prescribed calcium carbonate and vitamin D3, serum levels of calcium, phosphate, calcium-phosphate product and intact parathyroid hormone. All four bone metabolism markers within the range proposed by K/DOQI guidelines were achieved in 9.3%, 14.5% and 20.4% in the AIC, AMC and NC group, respectively.
Conclusions:
Patients with AIC and AMC are frequently found in the HD population. Screening for arterial calcifications in chronic kidney disease patients is suggested even in the early pre-dialysis period. The highest proportion of patients within the guidelines proposed range for bone and mineral metabolism markers was observed in the NC group. A longer period of data analysis is required in order to evaluate the possible role of some traditional and HD-specific risk factors for the development of arterial calcifications. The achievement of the K/DOQI guidelines is an important issue in the prevention of those conditions.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Hemodialysis III: Nursing Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Kidney Disease III: Interprofessional Care

